Brief: Rocket Pharmaceuticals Q3 EPS USD -0.75
06/11/2023 21:04
Nov 6 (Reuters) - Rocket Pharmaceuticals Q3 net income USD -61.9 million. * Q3 EPS USD -0.75
Recent news on Rocket Pharmaceuticals
See all newsRocket Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Rocket Pharmaceuticals, Inc. expected to post a loss of 42 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Rocket Pharmaceuticals posts Q2 profit helped by PRV sale
Brief: Rocket Pharmaceuticals Q2 EPS USD 1.08